ReviewFrontiers in immunology2026

Non-canonical and induced neoantigens as emerging sources of cancer-specific immunotherapy targets.

Viacheslav V Kudriavskii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.